News

Drug Long Used for Alcoholism Might Fight Severe COVID-19

TUESDAY, Nov. 23, 2021 (HealthDay News) — A widely available drug used to treat alcoholism has potential as a COVID-19 treatment, researchers say.The investigators found that people taking disulfiram (Antabuse) for alcoholism had a lower risk of infe…

Brain’s ‘White Matter’ Changes in People With Autism

TUESDAY, Nov. 23, 2021 (HealthDay News) — Teens and young adults with autism show marked differences in their brains’ white matter compared to those without the disorder, a new study finds.”If you think of gray matter as the computer, white matter i…

Animal Study Offers Hope for a Vaccine Against Lyme Disease

TUESDAY, Nov. 23, 2021 (HealthDay News) — An experimental Lyme disease vaccine shows promise in animal studies and could also help protect against other tick-borne diseases, researchers say.The vaccine — which relies on the same mRNA technology used …

La mayoría de los padres en una encuesta dijeron que sus hijos no están lo suficientemente agradecidos.

Most Parents Say Their Kids Aren’t Grateful Enough: Poll

Esa taza de café matutina puede afectar a los ritmos cardiacos

https://consumer.healthday.com/11-15-coffee-can-af…

Más evidencias de que las vacunas contra la COVID son seguras para los pacientes con cáncer

https://consumer.healthday.com/b-11-12-more-eviden…

Credit: HealthDay

Pfizer Says Its COVID-19 Vaccine Provides Full Protection to Adolescents

MONDAY, Nov. 22, 2021 (HealthDay News) — Pfizer Inc. said Monday that its COVID-19 vaccine provides long-term protection in youth ages 12 to 15 years, according to data from a company clinical trial that included more than 2,000 participants.In a com…

Booster Shots Prompt Stronger, Longer Protection Than Original Shots: Study

MONDAY, Nov. 22, 2021 (HealthDay News) — COVID-19 booster shots trigger much stronger and longer protection than full vaccination with two doses of the Pfizer or Moderna vaccines, according to a small study.It also found that the response to a booste…

Pfizer Says Its COVID Vaccine Provides Full Protection to Adolescents

MONDAY, Nov. 22, 2021 (HealthDay News) — Pfizer Inc. said Monday that its coronavirus vaccine provides long-term protection in youth ages 12-15, according to data from a company clinical trial that included more than 2,200 participants.In a company c…